Vanda Pharmaceuticals Inc. (VNDA) › Operating Cash FlowVanda Pharmaceuticals Inc. (VNDA) — Operating Cash FlowAnnual figures by period end, from SEC filings.2009-12-31: $169.34M2010-12-31: -$10.90M2011-12-31: -$28.41M2012-12-31: -$44.92M2013-12-31: -$39.59M2017-12-31: -$1.98M2018-12-31: $29.99M2019-12-31: $45.95M2020-12-31: $51.77M2021-12-31: $64.21M2022-12-31: $31.98M2023-12-31: $12.80M2024-12-31: -$15.76M2025-12-31: -$109.44M-$109.44M2009-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$109.44M—2026-02-12From 2025-01-012024-12-31-$15.76M-223.1%2026-02-12From 2024-01-012023-12-31$12.80M-60.0%2026-02-12From 2023-01-012022-12-31$31.98M-50.2%2025-02-14From 2022-01-012021-12-31$64.21M+24.0%2024-02-08From 2021-01-012020-12-31$51.77M+12.7%2023-02-09From 2020-01-012019-12-31$45.95M+53.2%2022-02-24From 2019-01-012018-12-31$29.99M—2021-02-11From 2018-01-012017-12-31-$1.98M—2020-02-26From 2017-01-012013-12-31-$39.59M—2014-02-25From 2013-01-012012-12-31-$44.92M—2014-02-25From 2012-01-012011-12-31-$28.41M—2014-02-25From 2011-01-012010-12-31-$10.90M-106.4%2013-02-26From 2010-01-012009-12-31$169.34M—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)